2021-03-19 13:45

Eurovaistinė – the first Lithuanian pharmacy network to invite for various vaccinations

In Vilnius, Kaunas, Klaipėda, Panevėžys and Šiauliai, Eurovaistinė’s ‘Wellbeing Clinics’ are launching where you can receive vaccinations for tick-borne encephalitis
In action
In action

Eurovaistinė is the first in Lithuania in seeking to contribute to popularising vaccinations, with the company has invested over 300 thousand euros in this scheme. There is also an expectation that soon, COVID-19 vaccinations will also be made available. Laimonas Devyžis, board chairman for Eurovaistinė, says that it has been a goal for a long time now to offer vaccinations in pharmacies.

Laimonas Devyžis, board chairman for Eurovaistinė
Laimonas Devyžis, board chairman for Eurovaistinė

“This service helps save time and not miss the necessary vaccinations. For a time now, we have been looking to ensure that our pharmacies would comply with prerequisite conditions for vaccination, and clients will be offered this service in the established ‘Wellbeing Clinics’,” L. Devyžis says.

From the presentation
From the presentation

Pharmacist Jovita Juodsnukytė explains that now is the right time to get vaccinated for tick-borne encephalitis because as warmer weather approaches ticks to become active, but there is still time to form an immunity.

From the presentation
From the presentation

Those looking to be vaccinated can register on the free of the charge phone line at 8 800 50005. All information about vaccinations is regularly renewed on the company website at apie-eurovaistine.lt and on social media. Pharmacies will offer adults vaccinations for tick-borne encephalitis and flu.

Vilnius (Ozo g. 25 and Gedimino pr. 18)

Kaunas (Savanorių pr. 255 and Karaliaus Mindaugo pr. 49-1),

Klaipėda (Taikos pr. 61),

Šiauliai (Tilžės g. 44)

Panevėžys (Ukmergės g. 23)

Experience in foreign countries indicates that with the launch of vaccinations in pharmacies, the number of vaccinated individuals rises. Vaccines are available in pharmacies across a significant number of countries – patients already value them in Norway, Portugal, Sweden, the UK and elsewhere.

Report mistake
Successfully sent
Thank you